02799nam 2200661Ia 450 991081473660332120240410110835.01-280-50549-49786610505494600-00-0359-51-60129-407-7(CKB)111087028237638(EBL)267477(OCoLC)191037936(SSID)ssj0000117302(PQKBManifestationID)11984687(PQKBTitleCode)TC0000117302(PQKBWorkID)10042652(PQKB)11443371(MiAaPQ)EBC267477(Au-PeEL)EBL267477(CaPaEBR)ebr10116435(CaONFJC)MIL50549(OCoLC)936834558(EXLCZ)9911108702823763820030916d2001 uy 0engur|n|---|||||txtccrCancer genomics[electronic resource] /guest editor, Robert L. Strausberg1st ed.Amsterdam IOS Press[c2001]1 online resource (91 p.)Disease markers,0278-0240 ;v. 17, no. 2Cover title."Special issue."0-585-45878-2 1-58603-251-8 Includes bibliographical references.Cover; Guest-Editorial: Talkin' Omics; Using Serial Analysis of Gene Expression to identify tumor markers and antigens; Cancer proteomics: The state of the art; Analysis of expression patterns: The scope of the problem, the problem of scope; Alternative spliced transcripts as cancer markers; Searching for pharmacogenomic markers: The synergy between omic and hypothesis-driven research; Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease; A comparison of gene expression signatures from breast tumors and breast tissue derived cell linesC282Y and H63D mutation frequencies in a population from central SpainANX7 as a bio-marker in prostate and breast cancer progressionThis work states that we are no longer satisfied to study a gene or gene product in isolation, but rather we strive to view each gene within the complex circuitry of a cell. It states that as a family of diseases, all cancer results from changes in the genome.Disease markers ;v. 17, no. 2.CancerGenetic aspectsTumorsGenetic aspectsCancerGenetic aspects.TumorsGenetic aspects.616.994042Strausberg Robert L1615222MiAaPQMiAaPQMiAaPQBOOK9910814736603321Cancer genomics3945320UNINA